Time Spent at Home Poststroke
- 1 January 2008
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 39 (1), 231-233
- https://doi.org/10.1161/strokeaha.107.493320
Abstract
Background and Purpose— Stroke outcome assessment requires some measure of functional recovery. Several instruments are in common use but all have recognized limitations. We examined duration of stay in the patient’s own home over the first 90 days since stroke—“home-time”—as an alternative outcome likely to show graded response with improved reliability. Methods— We examined prospectively collected data from the GAIN International trial using analysis of variance with Bonferroni contrasts of adjacent modified Rankin scale score categories. Results— We had full outcome data from 1717 of 1788 patients. Increasing home-time was associated with improved modified Rankin scale scores (PConclusions— Home-time offers a robust, useful, and easily validated outcome measure for stroke, particularly across better recovery levels.This publication has 7 references indexed in Scilit:
- Association Between Disability Measures and Healthcare Costs After Initial Treatment for Acute StrokeStroke, 2007
- Reliability of the Modified Rankin Scale Across Multiple RatersStroke, 2005
- Number Needed to Treat Estimates Incorporating Effects Over the Entire Range of Clinical OutcomesArchives of Neurology, 2004
- Sensitivity to changes in disability after stroke: a comparison of four scales useful in clinical trials.Journal of Rehabilitation Research and Development, 2003
- Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trialThe Lancet, 2000
- The Analysis of Multiple Endpoints in Clinical TrialsBiometrics, 1987